Table 3.
Prognostic factors for overall and disease free survival in study subjects.
| Variables | DFS | OS | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Histologic subtype (High vs Low) |
3.01 (1.82-4.97) | <0.001 | 3.22 (1.74-5.94) | <0.001 |
| Primary site (Trunk vs Extremity) |
1.80 (1.12-2.89) | 0.015 | 2.01 (1.07-3.77) | 0.029 |
| Margin status (negative vs positive) |
0.99 (0.60-1.61) | 0.958 | 1.09 (0.59-2.01) | 0.795 |
| Tumor burden (≤13 cm vs > 13cm) |
1.04 (0.64-1.68) | 0.874 | 1.25 (0.65-2.38) | 0.507 |
| Age (≤60yr vs >60yr) | 1.19 (0.76-1.88) | 0.450 | 1.52 (0.85-2.71) | 0.158 |
| Sex (Male) | 1.17 (0.75-1.82) | 0.480 | 1.05 (0.59-1.88) | 0.869 |
| Adjuvant Tx. | 1.29 (0.82-2.04) | 0.270 | 1.31 (0.73-2.35) | 0.361 |